Post-Transplant Cyclophosphamide as Sole Graft-versus-Host Disease Prophylaxis Is Feasible in Patients Undergoing Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia Using Matched Sibling Donors Biju George, Nisham PN, Anup J. Devasia, Uday Kulkarni, Anu Korula, Kavitha M. Lakshmi, Aby Abraham, Alok Srivastava, Vikram Mathews Biology of Blood and Marrow Transplantation Volume 24, Issue 3, Pages 494-500 (March 2018) DOI: 10.1016/j.bbmt.2017.10.034 Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 (A) Cumulative incidence of acute GVHD in the PTCY, MTX15, and MTX10 groups. (B) Cumulative incidence of chronic GVHD in the PTCY, MTX15, and MTX10 groups. Biology of Blood and Marrow Transplantation 2018 24, 494-500DOI: (10.1016/j.bbmt.2017.10.034) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 (A) Comparison of OS among the PTCY, MTX15, and MTX10 groups. (B) Comparison of event-free survival among patients receiving PTCY, MTX15, and MTX10. Biology of Blood and Marrow Transplantation 2018 24, 494-500DOI: (10.1016/j.bbmt.2017.10.034) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions